SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019905
Filing Date
2024-07-22
Accepted
2024-07-22 20:18:50
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 form4-07232024_120741.html 4  
1 form4-07232024_120741.xml 4 5631
  Complete submission text file 0001415889-24-019905.txt   7085
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTIVA BIOTHERAPEUTICS, INC. 4747 EXECUTIVE DRIVE, SUITE 1150 SAN DIEGO CA 92121
Business Address
Aslan Fred (Reporting) CIK: 0001909362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 241132703